Johannes H M Merks is an expert in Oncology at Princess Máxima Center (Netherlands). As of October 2026, ScienceLeadR ranks Johannes H M Merks in the top 1% of experts worldwide for Sarcoma. Johannes H M Merks has authored 258 publications, the most recent in 2026, and is an investigator in 4 clinical trials. SLR score: 876 (community average: 125). How the SLR is computed.

LeadR Profile

Johannes H M Merks Princess Máxima Center Netherlands
876 ScienceLeadR Reputation 876
Network Map

Oncology

Subspecialties: Pediatrics - Radiotherapy - Hematology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2003 - 2026

Source: PubMed

Princess Máxima Center

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 258

Citations

Citations: 6 049 1st author: 9 Last author: 43 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Dose-effect analysis of late dental adverse effects following radiation therapy in survivors of paediatric head and neck rhabdomyosarcoma.
PMID 42858853 — radiotherapy, tooth, rhabdomyosarcoma, probability, crowns, therapeutics, dentition
Radiother Oncol20260
Assessing the effect of chemotherapy dose reductions and time delay on event-free survival in Ewing Sarcoma: A retrospective analysis of the Euro Ewing 2012 trial.
PMID 42766959 — sarcoma, ewing, disease-free survival, drug therapy, sarcoma, drug tapering, therapeutics, chemotherapy
Eur J Cancer20260
Erratum: Omitting Bone Marrow Sampling in FDG-Avid Rhabdomyosarcoma With 2-[18F]FDG PET-Negative Marrow: Results From an International Retrospective Study.
PMID 42804723 — rhabdomyosarcoma, bone marrow, retrospective studies, fluorodeoxyglucose f18
J Clin Oncol Top journal20260
Chronic Kidney Disease in Children Within Five Years After Ifosfamide Chemotherapy for Childhood Cancer: A Dutch Pediatric Oncology Cohort Study.
PMID 42670233 — kidney diseases, ifosfamide, neoplasms, cohort studies, kidney, drug therapy, prevalence, child, chemotherapy
Cancer Med20260
Outcomes of Children With Orbital Rhabdomyosarcoma, 1991-2016: A Report From the International Soft Tissue Sarcoma Consortium (INSTRuCT).
PMID 42569952 — rhabdomyosarcoma, neoplasms, sarcoma, therapeutics, tissues, child
Pediatr Blood Cancer20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 2 2
Phase 2/Phase 3 1
Phase 4 1

By status:

Completed 2
Recruiting 1
Unknown 1

By type:

Interventional 4

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 3

Main Topics

LeadR Networks

Main global connection map